Inaba, Hiroto <br/><br/>
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.  [electronic resource] 

 -  Cancer  Jan 2010 
 - 98-105 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.24712  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cladribine--administration & dosage<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Infant<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Recurrence<br/>Retreatment<br/>Topotecan--administration & dosage